Ooi K, Ohkubo T, Kuwabara H, Higashigawa M, Kawasaki H, Kakitoh H, Kagawa Y, Inagaki S, Sumida K, Sakurai M
Department of Pharmacy, Social Insurance Hazu Hospital, Mie-Ken, Japan.
Cancer Invest. 1993;11(4):388-92. doi: 10.3109/07357909309018870.
We examined the effects of timing of administration of etoposide on cytosine arabinoside (ara-C) incorporation into DNA in L1210 ascites tumor. At 1 hr after injection of ara-C, 3-hr and 6-hr pretreatments with 15 mg/kg of etoposide increased ara-C incorporation to more than 200% as compared to that of ara-C given alone. Simultaneous administration of etoposide, however, decreased ara-C incorporation to 33% of that of ara-C alone. These results might explain the previously reported sequence dependency of the antitumor effect of etoposide and ara-C.
我们研究了依托泊苷给药时间对阿糖胞苷(ara-C)掺入L1210腹水瘤DNA的影响。注射ara-C后1小时,与单独给予ara-C相比,用15mg/kg依托泊苷预处理3小时和6小时可使ara-C掺入增加至200%以上。然而,同时给予依托泊苷可使ara-C掺入降至单独给予ara-C时的33%。这些结果可能解释了先前报道的依托泊苷和ara-C抗肿瘤作用的序列依赖性。